数智创新

Search documents
中国经济信息社成立数智创新研究院
Xin Hua Cai Jing· 2025-08-15 14:05
据了解,作为新华社经济信息业务主体,中经社先后组建数字经济研究中心、数据资产运营中心、新华 数字政府研究中心和新华指数研究院,形成"一院三中心"创新业务生态布局,构建起以数字政府、数字 经济、数据资产运营为重点方向的数字化业务"三驾马车"。中经社还推出八大垂直领域数字化应用系 统,为不同行业提供数智化解决方案。其中,行业洞察系统日前获评国家工业信息安全发展研究中 心"数字化产融合作成熟实践型解决方案"。 (文章来源:新华财经) 新华财经北京8月15日电(记者余蕊)中国经济信息社数智创新研究院15日在京成立。研究院旨在推动 人工智能等前沿技术在信息服务领域的创新应用,聚力打造经济信息"数智基座",助力新质生产力发 展。 "数智创新不仅仅是技术手段创新,更是产品服务、应用场景和生态体系运营模式的创新。"中经社总裁 兼数智创新研究院院长曹文忠在成立仪式上说。 曹文忠表示,中经社数智创新研究院立足于打造"国家级经济信息旗舰"总目标,围绕经济信息服务垂直 纵深领域,将深度结合大数据、大模型、人工智能等数智化前沿技术,开展系统性创新及全流程业务实 践,构建创新生态,为用户数字化转型提供持续赋能。未来,将重点聚焦数字政府、 ...
中国一乡一品产业发展母基金正式启动
FOFWEEKLY· 2025-08-11 10:03
来源:人民网 中金资本运营有限公司董事长单俊葆在致辞时表示,中金资本与中国民贸携手同行,用资本活水浇灌特色产业、以科技创新重塑乡村产业,打通制约 一乡一品产业高质量发展的堵点卡点,促进金融与产业链、供应链深度共生。 国务院发展研究中心国研智库董事长张诗雨作主旨发言。他指出,中国民贸在民族地区培育特色产业助力实现乡村振兴和共同富裕,这些实践成果总 结形成了《白皮书》可供借鉴、复制、推广的模式经验。 国务院参事室特约研究员、国家人力资源和社会保障部原党组副书记、副部长杨志明在致辞中对一乡一品数智赋能实体经济与乡村特色产业发展提出 五点工作建议:一是加快数字经济机制创新;二是加快数智赋能技术创新;三是加快产业融通和智慧场景创新;四是加快数字经济人才创新;五是加 快数据要素聚集环境创新。 会上,与会嘉宾共同登台揭牌,中国一乡一品产业发展母基金正式启动。 据了解,该基金由中国民族贸易促进会倡议,中国民贸一乡一品产业促进中心和中金资本共同发起设立。母基金将聚焦现代农业、智慧农业、食品及 农产品加工、民族文旅、现代商贸物流、生物医药、新能源、数字经济、供应链等产业和领域,引导社会资本高效助力乡村全面振兴和县域特色产业 高质 ...
国新健康发布首个专注“三医”协同大模型
Jing Ji Wang· 2025-06-30 08:53
Core Insights - GuoXin Health launched the "Tianshu·SanYi" large model and "Lingxi" intelligent platform, focusing on the integration of healthcare, medical insurance, and pharmaceuticals, marking a new phase in the digital transformation of the healthcare industry [1] - The initiative is driven by the State Council's "Artificial Intelligence+" action plan, leveraging over 20 years of industry experience and a service network covering more than 200 medical insurance clients, 800 hospitals, and over 20 drug regulatory agencies [1] Group 1 - The "Tianshu·SanYi" model addresses industry bottlenecks through four core capabilities: knowledge system foundation, professional knowledge graph empowerment, business insights navigation, and A2A global orchestration [2] - The knowledge system is built on high-quality datasets accumulated over two decades, establishing a "SanYi brain" knowledge hub that enhances the model's cognitive abilities [2] - The professional knowledge graph includes 3.55 million entity nodes and 150 million triples, enabling intelligent mapping of treatment norms, medication rules, and medical insurance policies [2] Group 2 - The model features four distinct characteristics: a growing model that supports real-time data updates and decision-making, a more accurate model with a hallucination rate below 3%, a customer-centric model that incorporates specialized knowledge, and a collaborative model that enhances operational efficiency [3] - The "Lingxi" platform focuses on integrating healthcare, medical insurance, and pharmaceutical services, creating a matrix of intelligent applications to reshape business processes and drive industry innovation [3]
国新健康(000503) - 2024年度业绩说明会活动记录
2025-05-12 10:16
Group 1: Company Overview and Strategy - Guoxin Health is focused on building a multi-level medical security system based on the "1+3+N" framework, addressing the needs for supplementary insurance and the pain points in commercial health insurance [2] - The company is implementing a "Digital Intelligence Innovation" strategy and has initiated the "AI in ALL" action to enhance its data processing capabilities and integrate AI technology across various medical fields [3] Group 2: Financial Performance - In 2024, the company achieved a revenue of approximately 356.9 million RMB, representing a year-on-year growth of 8.11%, while the net profit was approximately -11.5 million RMB, showing a reduction in losses by 85.72% [12] - The company’s revenue in 2024 compared to 2020 increased by about 150 million RMB, a growth rate of approximately 72% [8] Group 3: Market Position and Growth Potential - Guoxin Health has served over 70 regions under the DRG payment reform and maintains a leading market share in the DIP payment implementation across 40 regions [8] - The company is actively expanding its innovative services in health management, commercial insurance, and pharmaceutical innovation, which are expected to be new growth points [10] Group 4: Shareholder Engagement and Future Plans - As of March 31, 2025, the company had 70,199 shareholders, indicating a broad base of investor support [6] - The major shareholder plans to increase their stake in the company by investing between 100 million RMB and 200 million RMB within the next six months [13]